It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Protein knockdown using the auxin-inducible degron (AID) technology is useful to study protein function in living cells because it induces rapid depletion, which makes it possible to observe an immediate phenotype. However, the current AID system has two major drawbacks: leaky degradation and the requirement for a high dose of auxin. These negative features make it difficult to control precisely the expression level of a protein of interest in living cells and to apply this method to mice. Here, we overcome these problems by taking advantage of a bump-and-hole approach to establish the AID version 2 (AID2) system. AID2, which employs an OsTIR1(F74G) mutant and a ligand, 5-Ph-IAA, shows no detectable leaky degradation, requires a 670-times lower ligand concentration, and achieves even quicker degradation than the conventional AID. We demonstrate successful generation of human cell mutants for genes that were previously difficult to deal with, and show that AID2 achieves rapid target depletion not only in yeast and mammalian cells, but also in mice.
Auxin-inducible degron systems can be leaky and require high doses of auxin. Here the authors establish AID2 which uses an OsTIR1 mutant and the ligand 5-Ph-IAA to overcome these problems and establish AID-mediated target depletion in mice.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 National Institute of Genetics, Research Organization of Information and Systems (ROIS), Department of Chromosome Science, Mishima, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350); The Graduate University for Advanced Studies (SOKENDAI), Department of Genetics, Mishima, Japan (GRID:grid.275033.0) (ISNI:0000 0004 1763 208X)
2 National Institute of Genetics, Research Organization of Information and Systems (ROIS), Department of Chromosome Science, Mishima, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350)
3 National Institute of Genetics, Research Organization of Information and Systems (ROIS), Department of Chromosome Science, Mishima, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350); FIMECS, Inc., Fujisawa, Japan (GRID:grid.288127.6)
4 National Institute of Genetics, ROIS, Department of Gene Function and Phenomics, Mishima, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350)
5 The Graduate University for Advanced Studies (SOKENDAI), Department of Genetics, Mishima, Japan (GRID:grid.275033.0) (ISNI:0000 0004 1763 208X); National Institute of Genetics, ROIS, Department of Gene Function and Phenomics, Mishima, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350)
6 University of Tokyo, Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Bunkyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
7 The Graduate University for Advanced Studies (SOKENDAI), Department of Genetics, Mishima, Japan (GRID:grid.275033.0) (ISNI:0000 0004 1763 208X); National Institute of Genetics, ROIS, Department of Genomics and Evolutionary Biology, Mishima, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350); Sasaki Institute, Sasaki Foundation, Department of Cancer Genome Research, Chiyoda-ku, Japan (GRID:grid.419521.a) (ISNI:0000 0004 1763 8692)
8 Okayama University of Science, Department of Biochemistry, Okayama, Japan (GRID:grid.444568.f) (ISNI:0000 0001 0672 2184)
9 FIMECS, Inc., Fujisawa, Japan (GRID:grid.444568.f)
10 University of Tokyo, Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Bunkyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); University of Tokyo, Social Cooperation Program of Evolutional Chemical Safety Assessment System, LECSAS, Graduate School of Pharmaceutical Sciences, Bunkyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
11 The Graduate University for Advanced Studies (SOKENDAI), Department of Genetics, Mishima, Japan (GRID:grid.275033.0) (ISNI:0000 0004 1763 208X); National Institute of Genetics, ROIS, Department of Gene Function and Phenomics, Mishima, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350); Graduate School of Science, The University of Tokyo, Department of Biological Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)